CA Stock MarketDetailed Quotes

TTI Thiogenesis Therapeutics Corp

Watchlist
  • 0.610
  • +0.020+3.39%
15min DelayMarket Closed Dec 13 16:00 ET
28.08MMarket Cap-6.78P/E (TTM)

Thiogenesis Therapeutics Corp Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments
14.19%4.15M
7.06%4.97M
3.86%5.52M
14.21%7.08M
14.21%7.08M
125.03%3.63M
--4.64M
51.86%5.32M
9,805.77%6.2M
9,805.77%6.2M
-Cash and cash equivalents
14.19%4.15M
7.06%4.97M
3.86%5.52M
14.21%7.08M
14.21%7.08M
125.03%3.63M
--4.64M
51.86%5.32M
9,805.77%6.2M
9,805.77%6.2M
Receivables
62.37%73.54K
0.88%47.56K
404.29%95.62K
52.38%85.32K
52.38%85.32K
110.04%45.29K
118.22%47.15K
525.19%18.96K
-66.76%55.99K
-66.76%55.99K
-Accounts receivable
757.66%17.08K
-89.52%1.32K
-63.13%6.99K
-17.97%6K
-17.97%6K
-90.77%1.99K
-41.55%12.63K
525.19%18.96K
-44.62%7.32K
-44.62%7.32K
-Taxes receivable
30.40%56.47K
33.95%46.24K
--88.63K
469.48%79.31K
469.48%79.31K
--43.3K
--34.52K
----
--13.93K
--13.93K
-Other receivables
----
----
----
----
----
----
----
----
-77.62%34.74K
-77.62%34.74K
Prepaid assets
257.68%33K
414.61%46.5K
642.59%68.59K
110.69%81.38K
110.69%81.38K
--9.23K
--9.04K
--9.24K
--38.62K
--38.62K
Total current assets
15.39%4.25M
7.78%5.06M
6.38%5.69M
15.14%7.24M
15.14%7.24M
125.40%3.69M
110.06%4.7M
52.53%5.35M
2,623.46%6.29M
2,623.46%6.29M
Non current assets
Total non current assets
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Total assets
15.39%4.25M
7.78%5.06M
6.38%5.69M
15.14%7.24M
15.14%7.24M
125.40%3.69M
110.06%4.7M
52.53%5.35M
2,623.46%6.29M
2,623.46%6.29M
Liabilities
Current liabilities
Current liabilities
-66.95%105.92K
-11.83%308.45K
33.57%344.6K
457.66%1.71M
457.66%1.71M
295.94%320.44K
404.69%349.83K
-74.97%258K
-76.25%307.15K
-76.25%307.15K
Non current liabilities
Total non current liabilities
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Total liabilities
-66.95%105.92K
-11.83%308.45K
33.57%344.6K
457.66%1.71M
457.66%1.71M
295.94%320.44K
404.69%349.83K
-74.97%258K
-76.25%307.15K
-76.25%307.15K
Shareholders'equity
Share capital
40.81%15.67M
40.69%15.66M
40.69%15.66M
34.89%15.01M
34.89%15.01M
70.84%11.13M
70.97%11.13M
75.12%11.13M
957.18%11.13M
957.18%11.13M
-common stock
40.81%15.67M
40.69%15.66M
40.69%15.66M
34.89%15.01M
34.89%15.01M
70.84%11.13M
70.97%11.13M
75.12%11.13M
957.18%11.13M
957.18%11.13M
Retained earnings
-43.49%-13.16M
-54.04%-12.5M
-63.56%-11.85M
-80.30%-11.14M
-80.30%-11.14M
-63.88%-9.17M
-65.96%-8.11M
-64.93%-7.24M
-188.19%-6.18M
-188.19%-6.18M
Gains losses not affecting retained earnings
16.23%1.63M
19.76%1.6M
27.44%1.54M
60.52%1.66M
60.52%1.66M
121.25%1.41M
143.62%1.34M
135.16%1.2M
3,505.03%1.03M
3,505.03%1.03M
Total stockholders'equity
23.23%4.15M
9.36%4.76M
5.00%5.34M
-7.58%5.53M
-7.58%5.53M
116.52%3.37M
100.64%4.35M
105.64%5.09M
663.29%5.98M
663.29%5.98M
Total equity
23.23%4.15M
9.36%4.76M
5.00%5.34M
-7.58%5.53M
-7.58%5.53M
116.52%3.37M
100.64%4.35M
105.64%5.09M
663.29%5.98M
663.29%5.98M
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
--
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments 14.19%4.15M7.06%4.97M3.86%5.52M14.21%7.08M14.21%7.08M125.03%3.63M--4.64M51.86%5.32M9,805.77%6.2M9,805.77%6.2M
-Cash and cash equivalents 14.19%4.15M7.06%4.97M3.86%5.52M14.21%7.08M14.21%7.08M125.03%3.63M--4.64M51.86%5.32M9,805.77%6.2M9,805.77%6.2M
Receivables 62.37%73.54K0.88%47.56K404.29%95.62K52.38%85.32K52.38%85.32K110.04%45.29K118.22%47.15K525.19%18.96K-66.76%55.99K-66.76%55.99K
-Accounts receivable 757.66%17.08K-89.52%1.32K-63.13%6.99K-17.97%6K-17.97%6K-90.77%1.99K-41.55%12.63K525.19%18.96K-44.62%7.32K-44.62%7.32K
-Taxes receivable 30.40%56.47K33.95%46.24K--88.63K469.48%79.31K469.48%79.31K--43.3K--34.52K------13.93K--13.93K
-Other receivables ---------------------------------77.62%34.74K-77.62%34.74K
Prepaid assets 257.68%33K414.61%46.5K642.59%68.59K110.69%81.38K110.69%81.38K--9.23K--9.04K--9.24K--38.62K--38.62K
Total current assets 15.39%4.25M7.78%5.06M6.38%5.69M15.14%7.24M15.14%7.24M125.40%3.69M110.06%4.7M52.53%5.35M2,623.46%6.29M2,623.46%6.29M
Non current assets
Total non current assets --0--0--0--0--0--0--0--0--0--0
Total assets 15.39%4.25M7.78%5.06M6.38%5.69M15.14%7.24M15.14%7.24M125.40%3.69M110.06%4.7M52.53%5.35M2,623.46%6.29M2,623.46%6.29M
Liabilities
Current liabilities
Current liabilities -66.95%105.92K-11.83%308.45K33.57%344.6K457.66%1.71M457.66%1.71M295.94%320.44K404.69%349.83K-74.97%258K-76.25%307.15K-76.25%307.15K
Non current liabilities
Total non current liabilities --0--0--0--0--0--0--0--0--0--0
Total liabilities -66.95%105.92K-11.83%308.45K33.57%344.6K457.66%1.71M457.66%1.71M295.94%320.44K404.69%349.83K-74.97%258K-76.25%307.15K-76.25%307.15K
Shareholders'equity
Share capital 40.81%15.67M40.69%15.66M40.69%15.66M34.89%15.01M34.89%15.01M70.84%11.13M70.97%11.13M75.12%11.13M957.18%11.13M957.18%11.13M
-common stock 40.81%15.67M40.69%15.66M40.69%15.66M34.89%15.01M34.89%15.01M70.84%11.13M70.97%11.13M75.12%11.13M957.18%11.13M957.18%11.13M
Retained earnings -43.49%-13.16M-54.04%-12.5M-63.56%-11.85M-80.30%-11.14M-80.30%-11.14M-63.88%-9.17M-65.96%-8.11M-64.93%-7.24M-188.19%-6.18M-188.19%-6.18M
Gains losses not affecting retained earnings 16.23%1.63M19.76%1.6M27.44%1.54M60.52%1.66M60.52%1.66M121.25%1.41M143.62%1.34M135.16%1.2M3,505.03%1.03M3,505.03%1.03M
Total stockholders'equity 23.23%4.15M9.36%4.76M5.00%5.34M-7.58%5.53M-7.58%5.53M116.52%3.37M100.64%4.35M105.64%5.09M663.29%5.98M663.29%5.98M
Total equity 23.23%4.15M9.36%4.76M5.00%5.34M-7.58%5.53M-7.58%5.53M116.52%3.37M100.64%4.35M105.64%5.09M663.29%5.98M663.29%5.98M
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion------------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CA
Overall
Symbol
Price
% Chg

No Data